Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC. van Rhee F, et al. Among authors: stone k. Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4. Blood. 2018. PMID: 30181172 Free PMC article.
Siltuximab for multicentric Castleman disease.
Liu YC, Stone K, van Rhee F. Liu YC, et al. Among authors: stone k. Expert Rev Hematol. 2014 Oct;7(5):545-57. doi: 10.1586/17474086.2014.946402. Epub 2014 Aug 9. Expert Rev Hematol. 2014. PMID: 25110138
Treatment of Idiopathic Castleman Disease.
van Rhee F, Greenway A, Stone K. van Rhee F, et al. Among authors: stone k. Hematol Oncol Clin North Am. 2018 Feb;32(1):89-106. doi: 10.1016/j.hoc.2017.09.008. Hematol Oncol Clin North Am. 2018. PMID: 29157622 Free article. Review.
Storming the Castle with TCP.
van Rhee F, Stone K. van Rhee F, et al. Among authors: stone k. Blood. 2019 Apr 18;133(16):1697-1698. doi: 10.1182/blood-2019-02-900803. Blood. 2019. PMID: 31000513 Free article. No abstract available.
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
Nabel CS, Sameroff S, Shilling D, Alapat D, Ruth JR, Kawano M, Sato Y, Stone K, Spetalen S, Valdivieso F, Feldman MD, Chadburn A, Fosså A, van Rhee F, Lipkin WI, Fajgenbaum DC. Nabel CS, et al. Among authors: stone k. PLoS One. 2019 Jun 26;14(6):e0218660. doi: 10.1371/journal.pone.0218660. eCollection 2019. PLoS One. 2019. PMID: 31242229 Free PMC article.
Daratumumab for POEMS Syndrome.
Khan M, Stone K, van Rhee F. Khan M, et al. Among authors: stone k. Mayo Clin Proc. 2018 Apr;93(4):542-544. doi: 10.1016/j.mayocp.2018.02.001. Mayo Clin Proc. 2018. PMID: 29622102 No abstract available.
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease.
Fajgenbaum DC, Langan RA, Japp AS, Partridge HL, Pierson SK, Singh A, Arenas DJ, Ruth JR, Nabel CS, Stone K, Okumura M, Schwarer A, Jose FF, Hamerschlak N, Wertheim GB, Jordan MB, Cohen AD, Krymskaya V, Rubenstein A, Betts MR, Kambayashi T, van Rhee F, Uldrick TS. Fajgenbaum DC, et al. Among authors: stone k. J Clin Invest. 2019 Aug 13;129(10):4451-4463. doi: 10.1172/JCI126091. J Clin Invest. 2019. PMID: 31408438 Free PMC article.
1,272 results